Lekko przycinij podstaw do miejsca, w ktre zamierzasz poda lek
How to spot misleading GLP-1 patch marketing Red flags: any claim of containing "semaglutide" or "tirzepatide" (illegal without a prescription), before-and-after photos without clinical trial context, specific weight-loss promises ("lose 12+ lbs per month"), language like "Nature's Ozempic" or "works like Wegovy," and any implication of FDA review
And most importantlyWhy is this happening now, when Im finally seeing results
The study called for additional research to examine this question and urged patients to speak to their doctors before starting the drugs
Medically reviewed This page was last medically reviewed by Dr Adam Abbs on 8 Jan 2025
This effect may be explained by a DPP-4 inhibitor-dependent reduction in intestinal lipoprotein production and consecutive lowering of circulating chylomicrons (36, 37)